Hence, the current study aims to validate if the aforementioned hypothesis was valid and to further explore the mechanisms by which ELK1 enhances the chemoresistance to osteosarcoma cells through miR-134-targeted PTBP1. The gene discussed is ELK1; the disease is osteosarcoma.